Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Encompass Health CorpEHC · Entity 3460 | Director | July 15, 2026 | July 16, 2026 |
| IONIS PHARMACEUTICALS INCIONS · Entity 1182 | Director | July 15, 2026 | July 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Encompass Health Corp
Report date July 15, 2026 · Filed July 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Encompass Health Common StockSEC Table I · non-derivative | Direct | 49,643 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 85 · Balance 49,643 F1: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $109.88. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $109.88. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment.
IONIS PHARMACEUTICALS INC
Report date July 15, 2026 · Filed July 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 51,306 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Exercise / conversion · Acquired 5,220 · Balance 51,306 F1: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 2,301 |
Reported balance
After 2026-07-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-15 · Exercise / conversion · Disposed 5,220 · Balance 2,301 F2: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F3: Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award.
F2: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
F3: Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CONVERGYS CORP
Report date October 05, 2018 · Filed October 10, 2018
Section 16 reporting ended · disclosed 2018-10-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2018-10-05 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-10-05 · Disposition to issuer · Disposed 11,923 · Balance 33,612 F1: At the Effective Time (as defined in the Agreement and Plan of Merger, dated June 28, 2018 (as amended, the "Merger Agreement"), by and among the Company, SYNNEX Corporation, Delta Merger Sub I, Inc. and Concentrix CVG Corporation), these time-based restricted stock units and deferred stock units were converted into the right to receive $295,213.48 in cash, which amount will vest and be paid in accordance with the Merger Agreement and the applicable award agreements. Row 2 · 2018-10-05 · Disposition to issuer · Disposed 33,612 · Balance 0 F2: At the Effective Time, these shares were cancelled pursuant to the Merger Agreement in exchange for the right to receive $445,359 in cash and 4,245.20 shares of SYNNEX Corporation common stock having a market value of $89.14 per share, based on the closing price of SYNNEX common stock on October 5, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: At the Effective Time (as defined in the Agreement and Plan of Merger, dated June 28, 2018 (as amended, the "Merger Agreement"), by and among the Company, SYNNEX Corporation, Delta Merger Sub I, Inc. and Concentrix CVG Corporation), these time-based restricted stock units and deferred stock units were converted into the right to receive $295,213.48 in cash, which amount will vest and be paid in accordance with the Merger Agreement and the applicable award agreements.
F2: At the Effective Time, these shares were cancelled pursuant to the Merger Agreement in exchange for the right to receive $445,359 in cash and 4,245.20 shares of SYNNEX Corporation common stock having a market value of $89.14 per share, based on the closing price of SYNNEX common stock on October 5, 2018.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2022 Filed Jul 19, 2022 23:20 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionCommon Stock | 5,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000139 · edgardoc.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. F1 · shares: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 21:25 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | GrantRestricted Stock Unit · Derivative | 5,333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000121 · edgardoc.xml · derivative · entry 2 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,775 Underlying: Common Stock · 5,333 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F3 · derivative.exercise_date: Grant on July 1, 2022 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2022. F3 · derivative.expiration_date: Grant on July 1, 2022 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2022. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 21:25 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $38.06 | $0.00 |
DisclosureSEC source: 0000874015-22-000121 · edgardoc.xml · derivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2032-06-30 F1 · derivative.exercise_date: Grant on July 1, 2022 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2022. F1 · derivative.expiration_date: Grant on July 1, 2022 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2022. Read SEC document |
| June 10, 2022 Filed Jun 14, 2022 22:03 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionRestricted Stock Unit · Derivative | 3,555 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000108 · edgardoc.xml · derivative · entry 2 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,442 Underlying: Common Stock · 3,555 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F3 · derivative.exercise_date: Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid out in whole shares of Ionis common stock or cash as may be determined by Ionis. F3 · derivative.expiration_date: Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid out in whole shares of Ionis common stock or cash as may be determined by Ionis. Read SEC document |
| June 10, 2022 Filed Jun 14, 2022 22:03 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionCommon Stock | 3,555 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-22-000108 · edgardoc.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. F1 · shares: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. Read SEC document |
| May 05, 2022 Filed May 9, 2022 20:15 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 2,226 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-013829 · form4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,867 F1 · shares: Annual grant of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 17:52 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 121 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012242 · form4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,641 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $71.41. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 22:09 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 139 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-001730 · form4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,520 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $61.63. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 13:30 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 126 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-027253 · form4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,381 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $67.62. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 18:53 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 106 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-022097 · form4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,255 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $79.89. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 00:13 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionRestricted Stock Unit · Derivative | 1,778 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-21-000135 · edgardoc.xml · derivative · entry 4 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,997 Underlying: Common Stock · 1,778 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F4 · derivative.exercise_date: Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. F4 · derivative.expiration_date: Restricted Stock Units vest in four equal annual installments and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 00:13 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionRestricted Stock Unit · Derivative | 5,333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-21-000135 · edgardoc.xml · derivative · entry 3 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,775 Underlying: Common Stock · 5,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F3 · derivative.exercise_date: Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. F3 · derivative.expiration_date: Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 00:13 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionCommon Stock | 1,778 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-21-000135 · edgardoc.xml · nonDerivative · entry 2 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award. F1 · shares: Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 00:13 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionCommon Stock | 5,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-21-000135 · edgardoc.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,222 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award. F1 · shares: Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 21:51 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | GrantRestricted Stock Unit · Derivative | 5,333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-21-000113 · edgardoc.xml · derivative · entry 2 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,108 Underlying: Common Stock · 5,333 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F3 · derivative.exercise_date: Grant of July 1, 2021 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2021. F3 · derivative.expiration_date: Grant of July 1, 2021 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on July 1, 2021. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 21:51 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $40.05 | $0.00 |
DisclosureSEC source: 0000874015-21-000113 · edgardoc.xml · derivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2031-06-30 F1 · derivative.exercise_date: Grant of July 1, 2021 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2021. F1 · derivative.expiration_date: Grant of July 1, 2021 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2021. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 22:46 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionRestricted Stock Unit · Derivative | 3,555 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-21-000082 · edgardoc.xml · derivative · entry 2 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,775 Underlying: Common Stock · 3,555 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F3 · derivative.exercise_date: Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. F3 · derivative.expiration_date: Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 22:46 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionCommon Stock | 3,555 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-21-000082 · edgardoc.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,889 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award. F1 · shares: Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award. Read SEC document |
| May 06, 2021 Filed May 10, 2021 16:12 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 1,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-015985 · form4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,149 F1 · shares: Award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| April 15, 2021 Filed Apr 19, 2021 13:46 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 97 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-013954 · form4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,392 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $82.66. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| January 19, 2021 Filed Jan 20, 2021 17:35 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 95 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-002087 · form4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,295 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $83.42. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| October 16, 2020 Filed Oct 20, 2020 14:37 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 117 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-027245 · form4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,200 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $68.11. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| July 16, 2020 Filed Jul 20, 2020 21:06 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 121 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-021829 · form4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,083 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $65.21. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 21:51 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | GrantDirector Stock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $60.20 | $0.00 |
DisclosureSEC source: 0000874015-20-000107 · edgar.xml · derivative · entry 4 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2030-06-30 F5 · derivative.exercise_date: Grant of July 1, 2020 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2020. F5 · derivative.expiration_date: Grant of July 1, 2020 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. 100% of the shares subject to the option vest and become exercisable on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier. The option is exercisable to 0 shares on July 1, 2020. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 21:51 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | GrantRestricted Stock Units · Derivative | 5,333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000874015-20-000107 · edgar.xml · derivative · entry 3 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,333 Underlying: Common Stock · 5,333 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F4 · derivative.exercise_date: Grant of July 1, 2020 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on uly 1, 2020. F4 · derivative.expiration_date: Grant of July 1, 2020 to reporting person of Restricted Stock Unit award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. These Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and will be delivered to the reporting person on the July 15th following the vesting date. The Restricted Stock Unit is vested as to 0 shares on uly 1, 2020. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 21:51 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionRestricted Stock Units · Derivative | 1,778 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-20-000107 · edgar.xml · derivative · entry 2 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,332 Underlying: Common Stock · 1,778 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F3 · derivative.exercise_date: These Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. F3 · derivative.expiration_date: These Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 21:51 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionCommon Stock | 1,778 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-20-000107 · edgar.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards. F1 · shares: Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards. Read SEC document |
| June 10, 2020 Filed Jun 18, 2020 00:15 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionRestricted Stock Unit · Derivative | 3,556 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-20-000070 · edgar.xml · derivative · entry 2 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,665 Underlying: Common Stock · 3,556 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F3 · derivative.exercise_date: Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. F3 · derivative.expiration_date: Restricted Stock Units vest in four equal annual installments. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company. Read SEC document |
| June 10, 2020 Filed Jun 18, 2020 00:15 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | Exercise / conversionCommon Stock | 3,556 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-20-000070 · edgar.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award F1 · shares: Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit Award Read SEC document |
| May 06, 2020 Filed May 7, 2020 21:41 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 2,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015805 · form4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,962 F1 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| April 15, 2020 Filed Apr 17, 2020 13:14 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 104 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-013956 · form4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,658 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $69.76. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| January 16, 2020 Filed Jan 21, 2020 14:16 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 93 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-001992 · form4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,554 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $77.50. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| October 16, 2019 Filed Oct 17, 2019 15:22 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 111 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-030671 · form4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,461 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2019, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $64.71. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| July 16, 2019 Filed Jul 17, 2019 22:11 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 107 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-024797 · form4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,350 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share and the closing price was $64.39. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 22:54 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | GrantDirector Stock Option (right to buy) · Derivative | 16,000 | $0.00 Strike: $64.80 | $0.00 |
DisclosureSEC source: 0000874015-19-000108 · edgar.xml · derivative · entry 2 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2029-06-30 F3 · derivative.exercise_date: Grant of July 1, 2019 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, the first installment vesting on July 1, 2020. The option shall be fully vested and exercisable on July 1, 2023. The option is exercisable to 0 shares on July 1, 2019. F3 · derivative.expiration_date: Grant of July 1, 2019 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, the first installment vesting on July 1, 2020. The option shall be fully vested and exercisable on July 1, 2023. The option is exercisable to 0 shares on July 1, 2019. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 22:54 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | GrantRestricted Stock Units · Derivative | 7,110 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-19-000108 · edgar.xml · derivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,110 Underlying: Common Stock · 7,110 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F2 · derivative.exercise_date: Grant of July 1, 2019 to reporting person of Restricted Stock Unit Award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on July 1, 2020. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on July 1, 2023. The RSU is vested as to 0 shares on July 1, 2019. F2 · derivative.expiration_date: Grant of July 1, 2019 to reporting person of Restricted Stock Unit Award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on July 1, 2020. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on July 1, 2023. The RSU is vested as to 0 shares on July 1, 2019. Read SEC document |
| June 10, 2019 Filed Jun 12, 2019 21:16 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | GrantDirector Stock Option (right to buy) · Derivative | 32,000 | $0.00 Strike: $63.90 | $0.00 |
DisclosureSEC source: 0000874015-19-000075 · edgar.xml · derivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2029-06-09 F1 · derivative.exercise_date: Grant of June 10, 2019 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, the first installment vesting on June 10, 2020. The option shall be fully vested and exercisable on June 10, 2023. The option is exercisable to 0 shares on June 10, 2019. F1 · derivative.expiration_date: Grant of June 10, 2019 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, the first installment vesting on June 10, 2020. The option shall be fully vested and exercisable on June 10, 2023. The option is exercisable to 0 shares on June 10, 2019. Read SEC document |
| June 10, 2019 Filed Jun 13, 2019 00:15 UTC | IONIS PHARMACEUTICALS INC IONS · Entity 1182 | GrantRestricted Stock Units · Derivative | 14,221 | $0.00 | $0.00 |
DisclosureSEC source: 0000874015-19-000077 · edgar.xml · derivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,221 Underlying: Common Stock · 14,221 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. F2 · derivative.exercise_date: Grant of June 10, 2019 to reporting person of Restricted Stock Unit Award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on June 10, 2020. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on June 10, 2023. The RSU is vested as to 0 shares on June 10, 2019. F2 · derivative.expiration_date: Grant of June 10, 2019 to reporting person of Restricted Stock Unit Award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on June 10, 2020. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on June 10, 2023. The RSU is vested as to 0 shares on June 10, 2019. Read SEC document |
| May 03, 2019 Filed May 7, 2019 16:01 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 2,327 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-017543 · form4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,243 F1 · shares: Annual award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| April 23, 2019 Filed Apr 24, 2019 13:09 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 102 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-016097 · form4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,916 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share and the closing price was $61.37. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 21:09 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 94 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-002123 · form4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,814 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| October 15, 2018 Filed Oct 17, 2018 19:59 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 83 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-030493 · form4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,720 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2018, Encompass Health paid a dividend on its common stock of $0.27 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| October 05, 2018 Filed Oct 10, 2018 16:24 UTC | CONVERGYS CORP CVG · Entity 163096 | Disposition to issuerCommon Shares | 33,612 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-054685 · doc4.xml · nonDerivative · entry 2 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: At the Effective Time, these shares were cancelled pursuant to the Merger Agreement in exchange for the right to receive $445,359 in cash and 4,245.20 shares of SYNNEX Corporation common stock having a market value of $89.14 per share, based on the closing price of SYNNEX common stock on October 5, 2018. Read SEC document |
| October 05, 2018 Filed Oct 10, 2018 16:24 UTC | CONVERGYS CORP CVG · Entity 163096 | Disposition to issuerCommon Shares | 11,923 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-054685 · doc4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,612 F1 · price: At the Effective Time (as defined in the Agreement and Plan of Merger, dated June 28, 2018 (as amended, the "Merger Agreement"), by and among the Company, SYNNEX Corporation, Delta Merger Sub I, Inc. and Concentrix CVG Corporation), these time-based restricted stock units and deferred stock units were converted into the right to receive $295,213.48 in cash, which amount will vest and be paid in accordance with the Merger Agreement and the applicable award agreements. Read SEC document |
| July 16, 2018 Filed Jul 18, 2018 20:04 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 83 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-023486 · form4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,637 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| May 14, 2018 Filed May 16, 2018 16:29 UTC | CONVERGYS CORP CVG · Entity 163096 | GrantCommon Shares | 5,157 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-030504 · doc4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,535 F1 · price: Award of time-based restricted stock units. Read SEC document |
| May 04, 2018 Filed May 7, 2018 20:59 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 2,386 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-016518 · form4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,554 F1 · shares: Annual award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 22:25 UTC | Encompass Health Corp EHC · Entity 3460 | GrantHealthsouth Common Stock | 89 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-014890 · form4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,168 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| January 16, 2018 Filed Jan 18, 2018 21:45 UTC | Encompass Health Corp EHC · Entity 3460 | GrantHealthsouth Common Stock | 98 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-002084 · form4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,079 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
| October 16, 2017 Filed Oct 18, 2017 16:00 UTC | Encompass Health Corp HLS · Entity 3460 | GrantHealthsouth Common Stock | 111 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-029994 · form4.xml · nonDerivative · entry 1 HERMAN JOAN E · CIK 0001248398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,981 F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 16, 2017, HealthSouth paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.